0HRS.L

CVS Health Corporation
LSEUSDEQUITY DELAYED
Last price
93.09
▼ 0.93 (0.99%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
94.61
Prev close
94.02
Day high
93.80
Day low
93.15
Volume
2
Market cap
P/E (TTM)
0.16
52W range
64.39 – 93.80

Day trading desk

Current session · delayed
Gap from prior close
VWAP
93.45
-0.39% from price
Relative volume
0.06×
Quiet session
Session range
1.85%
93.00 – 94.72
Position in range
5%
Near session low
ATR (14D)
Daily true range
Prior day high
PDH
Prior day low
PDL
Bid / ask spread
Quote not published
Session volume
1.92K
Avg 34.80K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 0HRS.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
805.75K
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
May 21, 26
ROBBINS LARRY
Director
SELL 3.37M $317.47M Indirect
May 14, 26
NORWALK LESLIE V
Director
STOCK 1.45K $140.58K Direct
May 14, 26
AGUIRRE FERNANDO
Director
STOCK 1.56K $151.84K Direct
May 14, 26
BROWN C DAVID II
Director
STOCK 1.54K $150.00K Direct
May 14, 26
SANSONE GUY P
Director
STOCK 1.45K $140.58K Direct
May 14, 26
KIRBY JOHN SCOTT
Director
STOCK 1.45K $140.58K Direct
May 14, 26
BALSER JEFFREY R M.D., PH.D.
Director
STOCK 2.06K $199.94K Direct
May 8, 26
MANDADI TILAK
Officer
SELL 69.55K $6.23M Direct
Mar 31, 26
KHICHI SAMRAT S
General Counsel
STOCK 12.53K $899.98K Direct
Mar 31, 26
CAPOZZI HEIDI B
Officer
STOCK 10.03K $720.00K Direct
Mar 31, 26
JOYNER JOHN DAVID
Chief Executive Officer
STOCK 86.33K $6.20M Direct
Mar 31, 26
NELSON STEVEN H
Officer
STOCK 22.28K $1.60M Direct
Mar 31, 26
MANDADI TILAK
Officer
STOCK 22.28K $1.60M Direct
Mar 31, 26
SHAH PREM S
Officer
STOCK 25.06K $1.80M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BROWN C DAVID II
Director 129.32K Stock Award(Grant)
CAPOZZI HEIDI B
Officer 97.47K Stock Award(Grant)
COMPTON-PHILLIPS AMY
Officer 58.66K Stock Award(Grant)
COWHEY THOMAS F.
Chief Financial Officer 91.30K Stock Award(Grant)
FARAH ROGER N
Director 54.25K Stock Award(Grant)
JOYNER JOHN DAVID
Chief Executive Officer 231.21K Stock Award(Grant)
KHICHI SAMRAT S
General Counsel 71.56K Stock Award(Grant)
MILLON JEAN PIERRE
Director 112.22K Stock Award(Grant)
ROBBINS LARRY
Director Sale
SHAH PREM S
Officer 127.21K Stock Award(Grant)

Fundamentals

TTM · reported
Market cap
Enterprise value$181.30B
Revenue (TTM)$412.64B
Gross profit$56.31B
EBITDA$16.68B
Net income$4.89B
EPS (TTM)$6.01
Free cash flow$8.08B
Total cash$13.96B
Total debt$76.31B
Book value / share$62.37
Shares outstanding1.02B
Float1.28B
Short % of float
Dividend yield
Beta (5Y)0.60

Valuation & profitability ratios

Account required
Trailing P/E0.16
Forward P/E
PEG ratio
Price / sales
Price / book1.49
EV / revenue0.44
EV / EBITDA10.87
Gross margin13.65%
Operating margin3.86%
Profit margin1.18%
Return on equity6.21%
Return on assets2.97%
Debt / equity95.50
Current ratio0.87
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $104.55B +1.6%
Next quarter $106.88B +1.1%
Current year $417.46B +3.8%
Next year $429.05B +2.8%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders0.06%
Held by institutions90.86%
Institutions holding2.65K
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
EMA 12
EMA 26
EMA 50
RSI (14)
MACD (12,26,9)
Hist —
ATR (14)
Realised vol 30D
Annualised
Bollinger upper
20, 2σ
Bollinger lower
20, 2σ
50 / 200 cross
Trend bias

Options chain

Account required
ExpirySpot 93.09
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
Correlation to SPY
Realised vol 30D
Annualised
Market vol 1Y
SPY, annualised
Max drawdown 1Y
Peak to trough
Max drawdown 5Y
Peak to trough
ATR 14
Average true range
Beta (reported)
0.60
5Y monthly, from filing

Rating changes

362 on file
DateFirm ActionFromTo
Aug 19, 26 Argus Research MAINTAINED Buy Buy
Aug 12, 26 JP Morgan MAINTAINED Overweight Overweight
Aug 6, 26 UBS MAINTAINED Buy Buy
Aug 6, 26 Evercore ISI Group MAINTAINED Outperform Outperform
Aug 6, 26 Barclays MAINTAINED Overweight Overweight
Jul 25, 26 UBS MAINTAINED Buy Buy
Jul 14, 26 Truist Securities MAINTAINED Buy Buy
Jul 13, 26 Wells Fargo MAINTAINED Overweight Overweight
Jul 9, 26 RBC Capital MAINTAINED Outperform Outperform
Jul 7, 26 Cantor Fitzgerald MAINTAINED Overweight Overweight
Jun 23, 26 B of A Securities MAINTAINED Buy Buy
Jun 8, 26 Mizuho MAINTAINED Outperform Outperform

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.